• Ajugol, BNIP3 Mitophagy, and Alzheimer’s Disease

  2026-08-25

  A 2026 Neuropharmacology study identifies BNIP3-dependent mitophagy as a central mechanism through which ajugol improves mitochondrial integrity, synaptic injury, and cognitive performance in 5 × FAD mice. Its combination of behavioral, cellular, mitochondrial, and hippocampal loss-of-function experiments provides a useful framework for validating mitophagy-related gene-expression changes in Alzheimer’s disease models.

• Lactoferrin Potentiates Novobiocin Against E. coli

  2026-08-25

  Sanchez and Watts showed that bovine lactoferrin can restore the activity of Novobiocin against Escherichia coli, including mastitis-associated isolates that are normally poorly susceptible because of the Gram-negative outer membrane. Their time-kill experiments provide a useful model for studying host-factor–antibiotic cooperation and for designing follow-up antibacterial resistance research.

• Anlotinib Hydrochloride: From Mechanism to Translation

  2026-08-24

  Anlotinib hydrochloride illustrates how integrated VEGFR2, PDGFRβ, and FGFR1 inhibition can connect endothelial phenotypes with translational cancer research. This article presents a mechanism-led framework for assay design, competitive interpretation, and preclinical decision-making.

• Rifampin Workflows for Transcription Research

  2026-08-24

  Rifampin provides a practical bacterial transcription-initiation stop point for resistance mapping, RNA decay experiments, and synthetic circuit testing. This guide pairs reagent handling and time-course design with a clear comparison to light-controlled mammalian translation systems, helping researchers choose the right perturbation for each assay.

• NP-40 Lysis Buffer for FPR2/ALX Signaling

  2026-08-23

  NP-40 Lysis Buffer provides a mild, non-denaturing route to preserve signaling-state proteins and native interactions during neuroimmune sample preparation. This article translates FPR2/ALX–SYK–AKT findings into practical decisions for Western blotting, immunoprecipitation, and related assays.

• Epinephrine Bitartrate Research Workflows

  2026-08-22

  Build reproducible adrenergic signaling assays with Epinephrine Bitartrate across receptor activation, cellular function, and translational workflows. Learn how to exploit its broad α- and β-receptor activity while controlling stock stability, dose selection, vehicle effects, and supply-sensitive experimental design.

• Spatially Concentrated ABEs Correct PLP1 Mutations

  2026-08-22

  A 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve PLP1 mutation correction in oligodendrocytes without relying on greater intrinsic TadA* catalytic activity. By combining SunTag-mediated recruitment with a compact Cas9 variant suitable for AAV delivery, the authors link improved editing to restored PLP localization and myelination-related phenotypes.

• DMG-PEG2000-NH2: From Linker to Translation

  2026-08-21

  A mechanistic and translational analysis of DMG-PEG2000-NH2 as a reactive lipid–PEG platform, connecting amide chemistry, LNP formulation, siRNA encapsulation, and structure–activity lessons from optimized sulfonamides.

• Mithramycin A as a Transcriptional Probe

  2026-08-20

  Mithramycin A is an anticancer antibiotic that converts G-C-rich DNA recognition into a powerful framework for studying transcription, c-myc, differentiation, and pathway causality. This article connects its assay logic with the miR-24-3p/Sp1/PI3K findings while defining appropriate boundaries for cancer and cardiac research.

• Deferasirox Fe3+ Chelate in Lysosome Research

  2026-08-20

  Deferasirox Fe3+ chelate offers a chemically defined way to investigate ferric-iron biology alongside lysosomal stress. This article connects the compound to TCF25-driven ferritinophagy while emphasizing assay controls, chemical-form interpretation, and research limitations.

• Dibutyryl-cAMP, Sodium Salt in Signaling Assays

  2026-08-19

  Dibutyryl-cAMP, sodium salt provides a direct, cell-permeable route for probing cAMP–PKA biology in endothelial, immune, and neuronal models. This workflow-focused guide connects DBcAMP sodium salt to reproducible dose-response design, inflammation modulation studies, and hypothesis testing inspired by a murine lupus lung-injury study.

• Foretinib: From Kinase Mechanism to Translational Insight

  2026-08-19

  Foretinib (GSK1363089) offers a useful translational research framework for connecting Met and VEGFR pathway inhibition with tumor cell growth inhibition, motility, invasion, and metastasis. This article shows how to pair mechanistic assays with response metrics that distinguish proliferative arrest from cell death, improving interpretation across cell-based and xenograft models.

• Concanavalin A Targets Conserved Coronavirus Glycans

  2026-08-18

  The reference study identifies concanavalin A as a broad coronavirus entry inhibitor that recognizes conserved high-mannose N-glycans near the spike S2′ cleavage site. Its combined fusion, pseudovirus, authentic-virus, biochemical, and animal experiments indicate that glycan shielding can prevent spike activation, while also defining important limits for translating morphology-focused imaging into mechanistic glycan analysis.

• WNT5a/GSK3/β-Catenin in FAP Adipogenesis

  2026-08-18

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, mass cytometry, transcriptomics, and mouse models, it links pathway modulation to reduced fat infiltration and improved support of muscle satellite cell differentiation.

• Neuromedin S (rat): Protocol and QC Guide

  2026-08-17

  Neuromedin S (rat) provides a chemically defined rat peptide input for controlled studies of neuromedin U receptor signaling and related GPCR/G protein signaling workflows. It should be used for scientific research only, not as a diagnostic or therapeutic agent, and the available dossier does not establish assay potency or in vivo outcomes.

8481 records 1/566 page Next 12345 下5页 Last page